Ionis Pharmaceuticals
Price & Volume
Stats
See more52W Range | $33.33-$54.44 |
Market Cap | $5.6B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $803M |
Revenue Growth (YoY) | -7.2% |
Gross Profit (12 Mos) | -$257.8M |
Diluted EPS | -$2.44 |
News
See moreYahoo Finance • 3 months ago
Ionis announces proposed public offering of common stock
Yahoo Finance • 4 months ago
Praxis Precision Medicines to highlight their Epilepsy Portfolio at the International League Against Epilepsy 15th European Epilepsy Congress with six presentations
Yahoo Finance • 5 months ago
Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx™ System for Administration of nusinersen
Yahoo Finance • 7 months ago
Shareholders Will Probably Not Have Any Issues With Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) CEO Compensation
About
CEO | Dr. Brett P. Monia Ph.D. |
CFO | Ms. Elizabeth L. Hougen M.A., M.B.A., M.S. |
Address | 2855 Gazelle Court, Carlsbad, CA, United States, 92010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 927 |
